Neuroimaging biomarkers and CSF sTREM2 levels in Alzheimer's disease: a longitudinal study.

MLA

Nabizadeh, Fardin, et al. “Neuroimaging Biomarkers and CSF STREM2 Levels in Alzheimer’s Disease: A Longitudinal Study.” Scientific Reports, vol. 14, no. 1, July 2024, pp. 1–11. EBSCOhost, https://doi.org/10.1038/s41598-024-66211-w.

APA

Nabizadeh, F., Seyedmirzaei, H., & Karami, S. (2024). Neuroimaging biomarkers and CSF sTREM2 levels in Alzheimer’s disease: a longitudinal study. Scientific Reports, 14(1), 1–11. https://doi.org/10.1038/s41598-024-66211-w

Chicago

Nabizadeh, Fardin, Homa Seyedmirzaei, and Shaghayegh Karami. 2024. “Neuroimaging Biomarkers and CSF STREM2 Levels in Alzheimer’s Disease: A Longitudinal Study.” Scientific Reports 14 (1): 1–11. doi:10.1038/s41598-024-66211-w.